Cargando…
Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
Autores principales: | Palmeira, Vitória Andrade, Costa, Larissa Braga, Perez, Lucas Giandoni, Ribeiro, Victor Teatini, Lanza, Katharina, Silva, Ana Cristina Simões e |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Medicina / USP
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199295/ https://www.ncbi.nlm.nih.gov/pubmed/32401962 http://dx.doi.org/10.6061/clinics/2020/e1928 |
Ejemplares similares
-
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
por: Costa, Larissa Braga, et al.
Publicado: (2020) -
RETRACTED: Chloroquine or hydroxychloroquine for
COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020) -
Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017) -
Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
por: Biguetti, Claudia, et al.
Publicado: (2020) -
2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2020)